INGEST I Pilot Study

NCT03885310 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 9

Last updated 2022-08-10

No results posted yet for this study

Summary

INGEST I Pilot study is a feasibility study for evaluating the safety and efficacy of DCBs.

Conditions

  • Esophageal Stricture

Interventions

DEVICE

GIE Drug Coated Balloon

The GIE DCB is a balloon catheter with a 3 stage inflatable balloon coated with a proprietary coating containing the drug and carriers.

Sponsors & Collaborators

  • GIE Medical

    lead INDUSTRY

Principal Investigators

  • Kenneth Wang, MD · Mayo Clinic

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-02-24
Primary Completion
2024-12-31
Completion
2024-12-31

Countries

  • Paraguay

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03885310 on ClinicalTrials.gov